An observational study in Down Syndrome and Cervical Spine Instability in Down Syndrome, sponsored by Sohag University. Active, not recruiting at 1 site in Egypt. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-12-03.
Sponsored by Sohag University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Down Syndrome with a site in Egypt — 5 open to participants now, 7 under way, none of them phase 3. Down Syndrome · Egypt.
Among the 21 studies in Down Syndrome with a site in Egypt, this one is one of 6 that started in 2025, is one of 6 observational ones, and was the 15th registered.
439 studies on the registry are indexed under Down Syndrome; 99 are open to participants now.
Browse Down Syndrome studies →5 of the 21 studies in Down Syndrome with a site in Egypt are open now. Recruiting first, the newest first:
Raheel Sanad · Sites in Egypt
Ages 3–5 · Healthy volunteers
Badr University · Sites in Egypt
Ages 1–6
Ragaee Saeed Mahmoud · Sites in Egypt
Ages 10–16 · Healthy volunteers
Ain Shams University · Sites in Egypt
Ages 18+ · Healthy volunteers
Assiut University · Sites in Egypt
Ages 2–5
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 74 Down Syndrome studies recruiting now, 14 (19%) set no upper age limit and 57 (77%) stop at 75 or younger; 60 take children under 18; 19 take healthy volunteers.
This study: 2 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 158 across 145 observational studies indexed under Down Syndrome.
Median enrollment 40 across the 15 interventional studies, 63 across the 6 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 21 has an industry lead sponsor. The 10 most frequent:
Sohag University is the lead sponsor of 1,236 studies on the registry; 639 are open to participants now.
Sohag University has 1 study filed under Down Syndrome — fewer than ten, so there is no comparison to draw.
1 of the studies in Down Syndrome with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07260136Sohag UniversityCervical Spine Abnormalities in Down Syndrome | 2026-12-23 |
Add it to your calendar (.ics) → With an account.
Among the 21 studies in Down Syndrome with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The study aims to determine the prevalence,clinical presentations and radiographic cervical spine abnormalities associated Down syndrome in children at sohag university hospital
Aims to study the prevalence, clinical presentationsand radiographic cervical spine abnormalities associated with Down syndrome in children at sohag university hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Determine the prevalence, clinical presentations and radiographic cervical spine abnormalities associated with Down syndrome through study completion an average of 1 year .
Time frame: Asses the perivlance of cervical spine abnormalities in patient with Down syndrome of patients aged from 2 years up to 18 years ,using measure tool atlanoaxial instability in ct neck (ADI>3ml)and other mutliple measures ex(weight,height,eg.)
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Dec 2026, 14 months after the start.
Of 40 non-industry observational studies under Down Syndrome, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 14 months is below that.
Counting every sponsor, half of 55 studies reached it within 34 months; a quarter within 19 and three quarters within 71.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.